West Pharmaceutical Services

-7.02%

Live  

West Pharmaceutical Services is a leading global provider of innovative solutions for injectable drug administration. The company was founded in 1923 in Philadelphia, Pennsylvania and has since expanded to have a global presence with operations in North and South America, Europe, Asia, and Australia.
The company specializes in developing and manufacturing packaging, delivery systems, and diagnostic products for injectable drugs. This includes items such as syringe and cartridge components, closure systems, and self-injection systems. They also offer contract manufacturing services for pharmaceutical and biotechnology companies.
West Pharmaceutical Services is committed to providing high-quality, safe, and effective solutions for drug administration. Their products are used in a wide range of therapeutic areas including oncology, immunology, and diabetes.
In addition to their focus on product development and manufacturing, West Pharmaceutical Services also places a strong emphasis on sustainability and has implemented environmentally-friendly practices in their operations and product designs.
The company has a diverse workforce of over 9,500 employees and is dedicated to creating a positive and inclusive work environment. They also prioritize giving back to the community through their philanthropic efforts and involvement in various charitable initiatives.
Overall, West Pharmaceutical Services is a trusted partner for pharmaceutical and biotech companies, offering innovative solutions and a commitment to improving the global healthcare landscape.

West Pharmaceutical Services is a company that helps make sure medicines and vaccines are safe and easy to use. You know how when you go to the doctor, they sometimes give you a shot or a pill? Well, West makes special containers, like syringes and vials, that hold these medicines. They also create the things that keep the medicines safe inside those containers, like seals and caps.
West makes money by selling these containers and parts to big companies that make drugs and vaccines. When these companies need something to hold their medicine, or a way to deliver it easily and safely to patients, they buy West’s products.
West is successful for a few reasons. First, they have been around for a long time, so they know a lot about how to make these products really well. They work with many important companies, which helps them get steady business. Second, there are always new medicines and vaccines being developed, especially when people want to solve health problems. This means that West will keep having customers.
Looking ahead, West is likely to stay successful because:
1. Health is very important to everyone, and new medicines are being discovered all the time. This means West will always be needed.
2. They focus on making high-quality products, and when people trust a company, they usually keep coming back.
3. They’re also investing in new technology to make even better products, and this can help them attract more customers in the future.
So, West Pharmaceutical Services helps keep our medicines safe and easy to use, and they have a good plan for continuing their success!

MS4gRGl2ZX JzZSBQcm9k dWN0IFBvcn Rmb2xpbzog V2VzdCBQaG FybWFjZXV0 aWNhbCBTZX J2aWNlcyBo YXMgYSBkaX ZlcnNlIHBy b2R1Y3QgcG 9ydGZvbGlv LCBvZmZlcm luZyBhIHdp ZGUgcmFuZ2 Ugb2YgcGFj a2FnaW5nIG NvbXBvbmVu dHMgYW5kIG RlbGl2ZXJ5 IHN5c3RlbX MgZm9yIGlu amVjdGFibG UgZHJ1Z3Ms IGJpb2xvZ2 ljcywgYW5k IHZhY2Npbm VzLiBUaGlz IGVuYWJsZX MgdGhlIGNv bXBhbnkgdG 8gc2VydmUg YSB3aWRlIH ZhcmlldHkg b2YgY3VzdG 9tZXJzIGlu IHRoZSBwaG FybWFjZXV0 aWNhbCBhbm QgYmlvdGVj aG5vbG9neS BpbmR1c3Ry aWVzLjxicj 4yLiBFeHBl cnRpc2UgaW 4gRHJ1ZyBE ZWxpdmVyeS BTeXN0ZW1z OiBXZXN0IF BoYXJtYWNl dXRpY2FsIF NlcnZpY2Vz IGhhcyBhIH N0cm9uZyBl eHBlcnRpc2 UgaW4gZGV2 ZWxvcGluZy BhbmQgbWFu dWZhY3R1cm luZyBkcnVn IGRlbGl2ZX J5IHN5c3Rl bXMsIGluY2 x1ZGluZyBz eXJpbmdlIH N5c3RlbXMs IGF1dG8taW 5qZWN0b3Jz LCBhbmQgd2 VhcmFibGUg aW5qZWN0b3 IgZGV2aWNl cy4gVGhpcy BoYXMgaGVs cGVkIHRoZS Bjb21wYW55 IHRvIGJlY2 9tZSBhIHRy dXN0ZWQgcG FydG5lciBm b3IgcGhhcm 1hY2V1dGlj YWwgY29tcG FuaWVzIGxv b2tpbmcgZm 9yIGFkdmFu Y2VkIGFuZC Bpbm5vdmF0 aXZlIHNvbH V0aW9ucyBm b3IgZHJ1Zy BkZWxpdmVy eS48YnI+My 4gR2xvYmFs IFJlYWNoOi BXaXRoIG9w ZXJhdGlvbn MgaW4gb3Zl ciA1MCBjb3 VudHJpZXMs IFdlc3QgUG hhcm1hY2V1 dGljYWwgU2 VydmljZXMg aGFzIGEgZ2 xvYmFsIHJl YWNoIGFuZC BpcyB3ZWxs IHBvc2l0aW 9uZWQgdG8g c2VydmUgY3 VzdG9tZXJz IHdvcmxkd2 lkZS4gVGhp cyBhbHNvIH Byb3ZpZGVz IHRoZSBjb2 1wYW55IHdp dGggYSBkaX ZlcnNpZmll ZCByZXZlbn VlIHN0cmVh bSwgcmVkdW NpbmcgaXRz IGRlcGVuZG VuY2Ugb24g YW55IHNpbm dsZSBtYXJr ZXQuPGJyPj QuIENvbW1p dG1lbnQgdG 8gUXVhbGl0 eSBhbmQgSW 5ub3ZhdGlv bjogV2VzdC BQaGFybWFj ZXV0aWNhbC BTZXJ2aWNl cyBpcyBjb2 1taXR0ZWQg dG8gZGVsaX ZlcmluZyBo aWdoLXF1YW xpdHkgcHJv ZHVjdHMgYW 5kIHNlcnZp Y2VzIHRvIG l0cyBjdXN0 b21lcnMuIF RoZSBjb21w YW55IGludm VzdHMgaGVh dmlseSBpbi ByZXNlYXJj aCBhbmQgZG V2ZWxvcG1l bnQsIHdpdG ggYSBmb2N1 cyBvbiBpbm 5vdmF0aXZl IHNvbHV0aW 9ucyB0aGF0 IGltcHJvdm UgdGhlIHNh ZmV0eSBhbm QgZWZmaWNh Y3kgb2YgZH J1ZyBkZWxp dmVyeS48Yn I+NS4gU3Ry b25nIEN1c3 RvbWVyIFJl bGF0aW9uc2 hpcHM6IFRo cm91Z2ggaX RzIGRlZGlj YXRpb24gdG 8gY3VzdG9t ZXIgc2Vydm ljZSBhbmQg Y29sbGFib3 JhdGl2ZSBh cHByb2FjaC wgV2VzdCBQ aGFybWFjZX V0aWNhbCBT ZXJ2aWNlcy BoYXMgYnVp bHQgbG9uZy 10ZXJtIHJl bGF0aW9uc2 hpcHMgd2l0 aCBpdHMgY3 VzdG9tZXJz LiBUaGUgY2 9tcGFueSB3 b3JrcyBjbG 9zZWx5IHdp dGggaXRzIG NsaWVudHMg dG8gdW5kZX JzdGFuZCB0 aGVpciBuZW VkcyBhbmQg ZGV2ZWxvcC BjdXN0b21p emVkIHNvbH V0aW9ucyBm b3IgdGhlaX Igc3BlY2lm aWMgcHJvZH VjdHMuPGJy PjYuIFN1c3 RhaW5hYmxl IGFuZCBTb2 NpYWxseSBS ZXNwb25zaW JsZSBQcmFj dGljZXM6IF dlc3QgUGhh cm1hY2V1dG ljYWwgU2Vy dmljZXMgaX MgY29tbWl0 dGVkIHRvIH N1c3RhaW5h YmlsaXR5IG FuZCBoYXMg aW1wbGVtZW 50ZWQgdmFy aW91cyBpbm l0aWF0aXZl cyB0byByZW R1Y2UgaXRz IGVudmlyb2 5tZW50YWwg aW1wYWN0Li BUaGUgY29t cGFueSBhbH NvIHZhbHVl cyBjb3Jwb3 JhdGUgc29j aWFsIHJlc3 BvbnNpYmls aXR5LCBhY3 RpdmVseSBz dXBwb3J0aW 5nIGNvbW11 bml0aWVzIH Rocm91Z2gg dmFyaW91cy BwaGlsYW50 aHJvcGljIG VmZm9ydHMu PGJyPjcuIF N0cm9uZyBG aW5hbmNpYW wgUGVyZm9y bWFuY2U6IF dlc3QgUGhh cm1hY2V1dG ljYWwgU2Vy dmljZXMgaG FzIGEgc3Ry b25nIGZpbm FuY2lhbCBw ZXJmb3JtYW 5jZSwgd2l0 aCBjb25zaX N0ZW50IHJl dmVudWUgZ3 Jvd3RoIGFu ZCBwcm9maX RhYmlsaXR5 LiBUaGlzIG hhcyBlbmFi bGVkIHRoZS Bjb21wYW55 IHRvIGludm VzdCBpbiBp bm5vdmF0aW 9uIGFuZCBl eHBhbmQgaX RzIGdsb2Jh bCBwcmVzZW 5jZSB0aHJv dWdoIHN0cm F0ZWdpYyBh Y3F1aXNpdG lvbnMgYW5k IHBhcnRuZX JzaGlwcy4=

VGhlIFdlc3 QgUGhhcm1h Y2V1dGljYW wgU2Vydmlj ZXMgY29tcG FueSBpcyBh IGxlYWRpbm cgZ2xvYmFs IHByb3ZpZG VyIG9mIGlu bm92YXRpdm Ugc29sdXRp b25zIGZvci BpbmplY3Rh YmxlIGRydW cgYWRtaW5p c3RyYXRpb2 4gYW5kIGRl bGl2ZXJ5Li BUaGVpciBi dXNpbmVzcy Btb2RlbCBp cyBmb2N1c2 VkIG9uIG1h bnVmYWN0dX JpbmcgYW5k IHN1cHBseW luZyBwYWNr YWdpbmcsIG RlbGl2ZXJ5 LCBhbmQgYW RtaW5pc3Ry YXRpb24gc3 lzdGVtcyBm b3IgaW5qZW N0YWJsZSBt ZWRpY2luZX MsIGFsb25n IHdpdGggb2 ZmZXJpbmcg cmVsYXRlZC BzZXJ2aWNl cyBzdWNoIG FzIGNvbnRy YWN0IG1hbn VmYWN0dXJp bmcsIGRldm Vsb3BtZW50 IGFuZCB0ZX N0aW5nLCBh bmQgdGVjaG 5pY2FsIHN1 cHBvcnQuPG JyPlRoZXkg d29yayB3aX RoIHBoYXJt YWNldXRpY2 FsIGFuZCBi aW90ZWNobm 9sb2d5IGNv bXBhbmllcy B0byBkZXZl bG9wIGN1c3 RvbWl6ZWQg c29sdXRpb2 5zIHRoYXQg bWVldCB0aG VpciBzcGVj aWZpYyBkcn VnIGRlbGl2 ZXJ5IG5lZW RzLiBUaGlz IGluY2x1ZG VzIGRldmVs b3BpbmcgYW 5kIG1hbnVm YWN0dXJpbm cgdmlhbCBh bmQgc3lyaW 5nZSBzeXN0 ZW1zLCBzdG 9wcGVycywg YW5kIG90aG VyIGNvbXBv bmVudHMgZm 9yIGRydWcg cGFja2FnaW 5nLCBhcyB3 ZWxsIGFzIH NhZmV0eSBz eXN0ZW1zIG ZvciB0aGUg c2FmZSBhZG 1pbmlzdHJh dGlvbiBvZi BpbmplY3Rh YmxlIG1lZG ljaW5lcy48 YnI+V2VzdC BhbHNvIG9m ZmVycyBzZX J2aWNlcyBz dWNoIGFzIG NvbnRyYWN0 IG1hbnVmYW N0dXJpbmcg YW5kIGRldm ljZSBhc3Nl bWJseSwgd2 hlcmUgdGhl eSBwcm9kdW NlIGFuZCBh c3NlbWJsZS BwaGFybWFj ZXV0aWNhbC BwYWNrYWdp bmcgY29tcG 9uZW50cyBm b3IgdGhlaX IgY2xpZW50 cywgYW5kIG NvbnRyYWN0 IHBhY2thZ2 luZywgd2hl cmUgdGhleS Bwcm92aWRl IHBhY2thZ2 luZyBhbmQg bGFiZWxpbm cgc2Vydmlj ZXMgZm9yIH RoZWlyIGNs aWVudHMnIH Byb2R1Y3Rz Ljxicj5UaG VpciBidXNp bmVzcyBtb2 RlbCBpcyBi dWlsdCBvbi BhIGZvdW5k YXRpb24gb2 YgaW5ub3Zh dGlvbiBhbm QgY3VzdG9t ZXIgY29sbG Fib3JhdGlv biwgd2hlcm UgdGhleSB3 b3JrIGNsb3 NlbHkgd2l0 aCB0aGVpci BjbGllbnRz IHRvIGRldm Vsb3AgdGFp bG9yZWQgc2 9sdXRpb25z IHRoYXQgbW VldCB0aGVp ciB1bmlxdW UgcmVxdWly ZW1lbnRzLi BUaGlzIGFw cHJvYWNoIG hhcyBoZWxw ZWQgV2VzdC BiZWNvbWUg YSB0cnVzdG VkIHBhcnRu ZXIgZm9yIH BoYXJtYWNl dXRpY2FsIG FuZCBiaW90 ZWNobm9sb2 d5IGNvbXBh bmllcyB3b3 JsZHdpZGUs IHdpdGggYS BzdHJvbmcg Zm9jdXMgb2 4gcXVhbGl0 eSwgc2FmZX R5LCBhbmQg Y29tcGxpYW 5jZS4=

AI may pose certain challenges to West Pharmaceutical Services in several ways, but its overall impact will depend on how the company adapts and integrates these technologies into its operations.
1. Substitution: AI could enable new technologies or products that might substitute for traditional pharmaceutical delivery methods. For instance, advancements in digital health solutions and automated drug delivery systems could change how medications are administered, potentially affecting West’s existing product lines. However, West has a strong focus on innovation, which could provide opportunities to adapt its offerings to incorporate AI advancements instead of replacing them.
2. Disintermediation: The rise of self-administration and remote monitoring technologies could lead to disintermediation in the pharmaceutical supply chain. If patients increasingly manage their own drug delivery and monitoring through AI-powered devices, this could reduce demand for certain products that West offers. However, West could mitigate this risk by expanding its portfolio to include technologies that support home care and patient-centered solutions.
3. Margin Pressure: As AI-driven advancements create efficiencies in manufacturing and distribution, competitors might leverage these innovations to reduce costs or improve product quality. This could pressure West’s profit margins if it doesn’t keep pace with these developments. To counteract potential margin compression, West would need to invest in AI and automation in its own operations to improve efficiency and maintain competitiveness.
Overall, while AI presents certain risks to West Pharmaceutical Services, it also offers opportunities for growth and enhancement of its product and service offerings. The key will be how effectively the company can adapt to and leverage these technological changes.

The sensitivity of West Pharmaceutical Services’ earnings, cash flow, and valuation to changes in interest rates can be analyzed through several key factors:
1. Cost of Capital: Higher interest rates increase the cost of borrowing. For West Pharmaceutical, which may rely on debt to finance operations or expand its business, increased interest expenses can reduce net earnings. If the company has a significant amount of variable-rate debt, its cash flow might also be directly impacted as interest payments rise.
2. Discount Rate in Valuation: Valuation models, particularly discounted cash flow (DCF) analyses, use an estimated discount rate to calculate present value. An increase in interest rates typically raises the discount rate, leading to a lower present value of future cash flows. This can result in a decreased valuation of the company.
3. Impact on Investments: Higher interest rates may deter capital investments by the company, as the return on investments needs to exceed these higher rates to justify spending. This can lead to slower growth in revenues and cash flows in the long term.
4. Market Demand and Sales: Rising interest rates can impact overall economic conditions, potentially affecting demand for the healthcare products that West Pharmaceutical provides. If consumers and hospitals face higher financing costs, it might influence their purchasing decisions, ultimately affecting revenues.
5. Cash Flow Management: Changes in interest rates can also affect working capital management. For example, if rates rise and the company has to pay more interest on short-term borrowings, it may tighten cash flow availability for operations and other investments.
6. Sensitivity Analysis: Although exact sensitivities can vary, companies like West Pharmaceutical typically analyze their earnings and cash flow sensitivity to interest rate changes through scenario planning. A 1% increase in interest rates can be used as a benchmark to estimate the potential impact on earnings and cash flows.
In summary, West Pharmaceutical Services’ earnings, cash flow, and valuation can be negatively impacted by rising interest rates due to increased borrowing costs, higher discount rates in valuations, constraints on investments, and possible reductions in demand for its products. The overall sensitivity would depend on the company’s capital structure, operational efficiency, and market position.

CiAgICAgIC AgICAgIDxk aXYgc3R5bG U9J3dpZHRo OiAxMDAlOy BkaXNwbGF5 OiBmbGV4Oy BqdXN0aWZ5 LWNvbnRlbn Q6IGNlbnRl cjsnPgogIC AgICAgICAg ICAgICAgPG RpdiBzdHls ZT0nCiAgIC AgICAgICAg ICAgICAgIC AgZGlzcGxh eTogZmxleD sKICAgICAg ICAgICAgIC AgICAgICBh bGlnbi1pdG VtczogY2Vu dGVyOwogIC AgICAgICAg ICAgICAgIC AgIGJhY2tn cm91bmQtY2 9sb3I6ICNm MGY0Zjg7Ci AgICAgICAg ICAgICAgIC AgICAgYm9y ZGVyOiAxcH ggc29saWQg I2QxZTNmMD sKICAgICAg ICAgICAgIC AgICAgICBi b3JkZXItcm FkaXVzOiAx MHB4OwogIC AgICAgICAg ICAgICAgIC AgIHBhZGRp bmc6IDEwcH g7CiAgICAg ICAgICAgIC AgICAgICAg bWFyZ2luOi AyMHB4IDA7 CiAgICAgIC AgICAgICAg ICAgICAgZm 9udC1mYW1p bHk6ICJTZW dvZSBVSSIs IFJvYm90by wgc2Fucy1z ZXJpZjsKIC AgICAgICAg ICAgICAgIC AgICBib3gt c2hhZG93Oi AwIDJweCA2 cHggcmdiYS gwLCAwLCAw LCAwLjA1KT sKICAgICAg ICAgICAgIC AgICAgICBt YXgtd2lkdG g6IDkwMHB4 OwogICAgIC AgICAgICAg ICAgICAgIH dpZHRoOiAx MDAlOyc+Cg ogICAgICAg ICAgICAgIC AgICAgIDxp bWcgc3JjPS Jhc3NldHMv bG9nb3MvVz BEcm5JU2Fi Sks5WHlxVW ROYXAud2Vi cCIgYWx0PS JXZXN0IFBo YXJtYWNldX RpY2FsIFNl cnZpY2VzIi B0aXRsZT0i V2VzdCBQaG FybWFjZXV0 aWNhbCBTZX J2aWNlcyIg IGNsYXNzPS JpbWctZmx1 aWQiIGhlaW dodD05MCB3 aWR0aD05MC Bsb2FkaW5n PSdsYXp5Jy BzdHlsZT0n Ym9yZGVyLX JhZGl1czog NnB4Oyc+Cg ogICAgICAg ICAgICAgIC AgICAgIDxk aXYgc3R5bG U9J2ZsZXg6 IDE7IHRleH QtYWxpZ246 IGNlbnRlcj sgbWFyZ2lu LWxlZnQ6ID VweDsnPgog ICAgICAgIC AgICAgICAg ICAgICAgIC A8cCBzdHls ZT0nZm9udC 1zaXplOiAy NnB4OyBjb2 xvcjogIzMz MzsgbWFyZ2 luLWJvdHRv bTogMTVweD snPgogICAg ICAgICAgIC AgICAgICAg ICAgICAgIC Ag8J+TiCBX YW50IHRvIH JlYWQgbW9y ZSBhYm91dC BXZXN0IFBo YXJtYWNldX RpY2FsIFNl cnZpY2VzPw ogICAgICAg ICAgICAgIC AgICAgICAg ICA8L3A+Cg ogICAgICAg ICAgICAgIC AgICAgICAg ICA8YSBocm VmPSdpbmRl eC5waHA/cG FnZT1zaWdu dXAnIHN0eW xlPScKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIGJhY2tn cm91bmQtY2 9sb3I6ICMw MDdCRkY7Ci AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICBjb2 xvcjogI2Zm ZjsKICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IHBhZGRpbm c6IDEwcHgg MjBweDsKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIGJvcm Rlci1yYWRp dXM6IDVweD sKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIH RleHQtZGVj b3JhdGlvbj ogbm9uZTsK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIGZv bnQtd2VpZ2 h0OiBib2xk OwogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg bWFyZ2luLX JpZ2h0OiAx MHB4OwogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgdHJhbn NpdGlvbjog YmFja2dyb3 VuZC1jb2xv ciAwLjNzIG Vhc2U7Jwog ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgb25t b3VzZW92ZX I9J3RoaXMu c3R5bGUuYm Fja2dyb3Vu ZENvbG9yPS IjMDA1NmIz IicKICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IG9ubW91c2 VvdXQ9J3Ro aXMuc3R5bG UuYmFja2dy b3VuZENvbG 9yPSIjMDA3 QkZGIic+Ci AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICBTaW duIHVwIGZv ciBmcmVlCi AgICAgICAg ICAgICAgIC AgICAgICAg IDwvYT4KCi AgICAgICAg ICAgICAgIC AgICAgICAg IDxzcGFuIH N0eWxlPSdt YXJnaW46ID AgOHB4OyBj b2xvcjogIz U1NTsnPm9y PC9zcGFuPg oKICAgICAg ICAgICAgIC AgICAgICAg ICAgPGEgaH JlZj0naW5k ZXgucGhwP3 BhZ2U9bG9n aW4nIHN0eW xlPScKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIGNvbG9y OiAjMDA3Qk ZGOwogICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgdGV4dC1k ZWNvcmF0aW 9uOiB1bmRl cmxpbmU7Ci AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICBmb2 50LXdlaWdo dDogNTAwOy c+CiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC Bsb2cgaW4K ICAgICAgIC AgICAgICAg ICAgICAgIC AgPC9hPgoK CiAgICAgIC AgICAgICAg ICAgICAgIC AgIDxwIHN0 eWxlPSdtYX JnaW4tdG9w OiAxNXB4Oy Bmb250LXNp emU6IDEzcH g7IGZvbnQt d2VpZ2h0Oi Bib2xkOyBj b2xvcjogI2 QzMmYyZjsn PgogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg 8J+OgSBGcm VlIGRvd25s b2FkISA8aT 4iVGhlIENo ZWNrbGlzdC BWYWx1ZSBJ bnZlc3Rvci DigJQgQSBT bWFydGVyIF dheSB0byBQ aWNrIFN0b2 NrcyI8L2k+ CiAgICAgIC AgICAgICAg ICAgICAgIC AgIDwvcD4K CiAgICAgIC AgICAgICAg ICAgICAgIC AgIDwhLS0K ICAgICAgIC AgICAgICAg ICAgICAgIC AgPGRpdiBz dHlsZT0nbW FyZ2luLXRv cDogMTJweD sgZm9udC1z aXplOiAxM3 B4OyBjb2xv cjogIzQ0ND snPgogICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgU2lnbiB1 cCBub3cgYW 5kIGdldCBv dXIgZnJlZS BlQm9vayAK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIDxi PlRoZSBDaG Vja2xpc3Qg VmFsdWUgSW 52ZXN0b3Ig 4oCUIEEgU2 1hcnRlciBX YXkgdG8gUG ljayBTdG9j a3M8L2I+Ci AgICAgICAg ICAgICAgIC AgICAgICAg IDwvZGl2Pg ogICAgICAg ICAgICAgIC AgICAgICAg ICAtLT4KIC AgICAgICAg ICAgICAgIC AgICAgICAg PCEtLQogIC AgICAgICAg ICAgICAgIC AgICAgICA8 ZGl2IHN0eW xlPSdtYXJn aW4tdG9wOi AxNnB4OyBm b250LXNpem U6IDE0cHg7 IGNvbG9yOi AjNDQ0OyBm b250LWZhbW lseTogLWFw cGxlLXN5c3 RlbSwgQmxp bmtNYWNTeX N0ZW1Gb250 LCBTZWdvZS BVSSwgUm9i b3RvLCBIZW x2ZXRpY2Eg TmV1ZSwgc2 Fucy1zZXJp ZjsgbGluZS 1oZWlnaHQ6 IDEuNjsnPg ogICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgSG F2ZSB5b3Ug aGVhcmQgYW JvdXQgb3Vy IHNob3J0ID xzdHJvbmcg c3R5bGU9J2 ZvbnQtd2Vp Z2h0OiA2MD A7Jz5EYWls eSBWaWRlby BOZXdzbGV0 dGVyPC9zdH Jvbmc+Pwog ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgPGEg aHJlZj0naH R0cHM6Ly93 d3cuaW5zaW dodGZ1bHZh bHVlLmNvbS 9uZXdzbGV0 dGVyLnBocC cgdGFyZ2V0 PSdfYmxhbm snIHN0eWxl PSdjb2xvcj ogIzAwN0JG RjsgdGV4dC 1kZWNvcmF0 aW9uOiBub2 5lOyBmb250 LXdlaWdodD ogNTAwOyBt YXJnaW4tbG VmdDogNnB4 Oyc+CiAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgRm luZCBvdXQg bW9yZQogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgPC9hPg ogICAgICAg ICAgICAgIC AgICAgICAg ICA8L2Rpdj 4KICAgICAg ICAgICAgIC AgICAgICAg ICAgLS0+Ci AgICAgICAg ICAgICAgIC AgICAgPC9k aXY+CiAgIC AgICAgICAg ICAgICA8L2 Rpdj4KICAg ICAgICAgIC AgPC9kaXY+ CiAgICAgIC AgICAgIAog ICAgICAgIA ogICAgICAg IDxzcGFuIG NsYXNzPSdi bHVycmVkLX RleHQnPgog ICAgICAgIC AgICBWMlZ6 ZENCUWFHIE Z5YldGalpY VjAgYVdOaG JDQlRaWCBK MmFXTmxjeU JwIGN5QmhJ SGRsYkcgd3 RhMjV2ZDI0 ZyBZMjl0Y0 dGdWVTIEJw YmlCMGFHVW cgY0doaGNt MWhZMiBWMW RHbGpZV3dn IFlXNWtJR0 pwYjMgUmxZ Mmh1YjJ4di BaM2tnYzJW amRHIDl5Y3 l3Z2NISnAg YldGeWFXeD VJRyBadlkz VnphVzVuIE lHOXVJSFJv WlMgQmtaWE 5wWjI0ZyBZ VzVrSUcxaG JuIFZtWVdO MGRYSnAgYm 1jZ2IyWWdj RyBGamEyRm 5hVzVuIElH RnVaQ0JrWl cgeHBkbVZ5 ZVNCeiBlWE 4wWlcxeklH IFp2Y2lCcG JtcGwgWTNS aFlteGxJRy BSeWRXZHpM aUJJIFpYSm xJR0Z5WlMg QnpiMjFsSU dsdSBkR1Z5 WlhOMGFXID VuSUdaaFkz UnogSUdGaW IzVjBJSCBS b1pTQmpiMj F3IFlXNTVP anhpY2ogNH hMaUE4YzNS eSBiMjVuUG tocGMzIFJ2 Y25rOEwzTj AgY205dVp6 NDZJRiBkbG MzUWdVR2ho IGNtMWhZMl YxZEcgbGpZ V3dnVTJWeS BkbWxqWlhN Z2QyIEZ6SU dadmRXNWsg WldRZ2FXNG dNVCBreU15 QmllU0JoIE lIQm9ZWEp0 WVcgTnBjM1 FnYm1GdCBa V1FnVjJsc2 JHIGxoYlNC SUxpQlggWl hOMExpQlVh RyBVZ1kyOX RjR0Z1IGVT QnpkR0Z5ZE cgVmtJSGRw ZEdnZyBkR2 hsSUhCeWIy IFIxWTNScG IyNGcgYjJZ Z2NuVmlZbS BWeUlHTnZi WEJ2IGJtVn VkSE1nWm0g OXlJSFJvWl NCdyBhR0Z5 YldGalpYIF YwYVdOaGJD QnAgYm1SMW MzUnllUyA0 OFluSStNaT RnIFBITjBj bTl1WnogNU pibTV2ZG1G MCBhWFpsSU ZCeWIyIFIx WTNSelBDOX ogZEhKdmJt YytPaSBCWF pYTjBJR2x6 IElISmxZMj luYm0gbDZa V1FnWm05eS BJR1JsZG1W c2IzIEJwYm 1jZ2RHaGwg SUdacGNuTj BJSCBObGJH WXRjMlZoIG JHbHVaeUJ5 ZFcgSmlaWE lnYzNSdiBj SEJsY2l3Z2 QyIGhwWTJn Z2NtVjIgYj J4MWRHbHZi bSBsNlpXUW dhRzkzIElH MWxaR2xqWV ggUnBiMjV6 SUdGeSBaU0 J6ZEc5eVpX IFFnWVc1a0 lHUnAgYzNC bGJuTmxaQy A0Z1ZHaHBj eUJwIGJtNX ZkbUYwYVcg OXVJSEJ5Yj NacCBaR1Zr SUdKbGRIIF JsY2lCemRH VnkgYVd4cG RIa2dZVyA1 a0lHRmpZMl Z6IGMybGlh V3hwZEgga2 dabTl5SUds dSBhbVZqZE dGaWJHIFVn WkhKMVozTX UgUEdKeVBq TXVJRCB4em RISnZibWMr IFIyeHZZbU ZzSUYgSmxZ V05vUEM5ei BkSEp2Ym1j K09pIEJYWl hOMElHOXcg WlhKaGRHVn pJRyBsdUlH MTFiSFJwIG NHeGxJR052 ZFcgNTBjbW xsY3lCaCBj bTkxYm1RZ2 RHIGhsSUhk dmNteGsgTE NCd2NtOTJh VyBScGJtY2 djMlZ5IGRt bGpaWE1nZE cgOGdZU0Jr YVhabCBjbk 5sSUhKaGJt IGRsSUc5bU lHTnMgYVdW dWRITWdhVy A0Z2RHaGxJ SEJvIFlYSn RZV05sZFgg UnBZMkZzSU dGdSBaQ0Jp YVc5MFpXIE 5vYm05c2Iy ZDUgSUdsdV pIVnpkSCBK cFpYTXVJRl JvIFpXbHlJ R2RzYjIgSm hiQ0J3Y21W eiBaVzVqWl NCbGJtIEZp YkdWeklIUm 8gWlcwZ2RH OGdiVyBWbG RDQjJZWEo1 IGFXNW5JSE psWjMgVnNZ WFJ2Y25rZy BjbVZ4ZFds eVpXIDFsYm 5SeklHRnUg WkNCamRYTj BiMiAxbGNp QnVaV1ZrIG N5NDhZbkkr TkMgNGdQSE 4wY205dSBa ejVUZFhOMF lXIGx1WVdK cGJHbDAgZV NCSmJtbDBh VyBGMGFYWm xjend2IGMz UnliMjVuUG ogb2dWR2hs SUdOdiBiWE JoYm5rZ2FH IEZ6SUcxaF pHVWcgWTI5 dGJXbDBiVy BWdWRITWdk RzhnIGMzVn pkR0ZwYm0g RmlhV3hwZE hrZyBZVzVr SUdGcGJYIE 1nZEc4Z2Nt VmsgZFdObE lHbDBjeSBC bGJuWnBjbT l1IGJXVnVk R0ZzSUcgbH RjR0ZqZENC MCBhSEp2ZF dkb0lIIFpo Y21sdmRYTW cgYVc1cGRH bGhkRyBsMl pYTXNJR2x1 IFkyeDFaR2 x1WnkgQjNZ WE4wWlNCeS BaV1IxWTNS cGIyIDRnWV c1a0lHVnUg WlhKbmVTQm xabSBacFky bGxibU41IE lIQnliMmR5 WVcgMXpMan hpY2o0MSBM aUE4YzNSeW IyIDVuUGxC aGNuUnUgWl hKemFHbHdj eSBCM2FYUm 9JRUpwIGIz UmxZMmdnUT IgOXRjR0Z1 YVdWeiBQQz l6ZEhKdmJt IGMrT2lCWF pYTjAgSUdO dmJHeGhZbS A5eVlYUmxj eUIzIGFYUm 9JRzFoYm4g a2dZbWx2ZE dWaiBhQ0Jt YVhKdGN5IE IwYnlCa1pY WmwgYkc5d0 lHTjFjMyBS dmJXbDZaV1 FnIFpISjFa eUJrWlcgeH BkbVZ5ZVNC eiBlWE4wWl cxeklHIEZ1 WkNCd1lXTn IgWVdkcGJt Y2djMiA5c2 RYUnBiMjV6 IExDQndZWE owYVcgTjFi R0Z5YkhrZy BabTl5SUdO dmJYIEJzWl hnZ1ltbHYg Ykc5bmFXTn pJRyBGdVpD QnpjR1ZqIG FXRnNkSGtn Y0cgaGhjbT FoWTJWMSBk R2xqWVd4ek xqIHhpY2o0 MkxpQTggYz NSeWIyNW5Q ayBsdWRtVn pkRzFsIGJu UWdhVzRnVW kgWmhiWEE3 UkR3diBjM1 J5YjI1blBq IG9nVkdobE lHTnYgYlhC aGJua2dhVy A1MlpYTjBj eUJ6IGFXZH VhV1pwWTIg RnVkR3g1SU dsdSBJSEps YzJWaGNtIE 5vSUdGdVpD QmsgWlhabG JHOXdiVyBW dWRDQjBieU JwIGJtNXZk bUYwWlMgQm hibVFnYVcx dyBjbTkyWl NCcGRIIE1n Y0hKdlpIVm ogZENCdlpt WmxjbSBsdV ozTXNJR1Z1 IGMzVnlhVz VuSUggUm9a WGtnY21WdC BZV2x1SUdG MElIIFJvWl NCbWIzSmwg Wm5KdmJuUW diMiBZZ2RH aGxJR2x1IF pIVnpkSEo1 TGogeGljaj QzTGlBOCBj M1J5YjI1bl BsIEYxWVd4 cGRIa2cgUV hOemRYSmhi bSBObFBDOX pkSEp2IGJt YytPaUJYWl ggTjBJSEJz WVdObCBjeU JoSUhOMGNt IDl1WnlCbG JYQm8gWVhO cGN5QnZiaS BCeGRXRnNh WFI1IElHTn ZiblJ5YjIg d2dZVzVrSU hKbCBaM1Zz WVhSdmNuIG tnWTI5dGNH eHAgWVc1al pTd2dkMiBo cFkyZ2dhWE 1nIFkzSjFZ MmxoYkMgQm 5hWFpsYmlC MCBhR1VnWT NKcGRHIGxq WVd3Z2JtRj AgZFhKbElH OW1JSCBSb1 pXbHlJSEJ5 IGIyUjFZM1 J6SUcgbHVJ SEIxWW14cC BZeUJvWldG c2RHIGdnWV c1a0lITmgg Wm1WMGVTND hZbiBJK09D NGdQSE4wIG NtOXVaejVU ZEcgOWpheU JNYVhOMCBh VzVuUEM5em RIIEp2Ym1j K09pQlggWl hOMElGQm9Z WCBKdFlXTm xkWFJwIFky RnNJRk5sY2 4gWnBZMlZ6 SUdseiBJSE IxWW14cFky IHg1SUhSeV lXUmwgWkNC dmJpQjBhRy BVZ1RtVjNJ Rmx2IGNtc2 dVM1J2WTIg c2dSWGhqYU dGdSBaMlVn ZFc1a1pYIE lnZEdobElI UnAgWTJ0bG NpQnplVyAx aWIyd2dWMU 5VIExqeGlj ajQ1TGkgQT hjM1J5YjI1 biBQa052Yl cxMWJtIGww ZVNCRmJtZG ggWjJWdFpX NTBQQyA5em RISnZibWMr IE9pQlVhR1 VnWTIgOXRj R0Z1ZVNCcC BjeUJwYm5a dmJIIFpsWk NCcGJpQjIg WVhKcGIzVn pJRyBOdmJX MTFibWwwIG VTQnBibWww YVcgRjBhWF psY3lCaCBi bVFnY0docG JHIEZ1ZEdo eWIzQnAgWX lCbFptWnZj biBSekxDQn BibU5zIGRX UnBibWNnYz MgVndjRzl5 ZEdsdSBaeU JsWkhWallY IFJwYjI1aG JDQncgY205 bmNtRnRjeS BCaGJtUWdh R1ZoIGJIUm 9ZMkZ5WlMg QmhZMk5sYz NNdSBQR0p5 UGpFd0xpIE E4YzNSeWIy NW4gUGtsdV pIVnpkSCBK NUlGSmxZMj luIGJtbDBh Vzl1UEMgOX pkSEp2Ym1j KyBPaUJYWl hOMElHIGho Y3lCeVpXTm wgYVhabFpD QnVkVyAxbG NtOTFjeUJo IGQyRnlaSE 1nWVcgNWtJ SEpsWTI5bi BibWwwYVc5 dUlHIFp2Y2 lCcGRITWcg WTI5dWRISn BZbiBWMGFX OXVjeUIwIG J5QjBhR1Vn Y0cgaGhjbT FoWTJWMSBk R2xqWVd3Z2 FXIDVrZFhO MGNua3MgSU hCaGNuUnBZ MyBWc1lYSn NlU0JwIGJp QmhjbVZoY3 kgQnpkV05v SUdGeiBJSE J5YjJSMVkz IFFnYVc1dW IzWmggZEds dmJpQmhibS BRZ1kyOXlj Rzl5IFlYUm xJSE52WTIg bGhiQ0J5Wl hOdyBiMjV6 YVdKcGJHIG wwZVM0Z1BH SnkgUGxSb1 pYTmxJRyBa aFkzUnpJR2 hwIFoyaHNh V2RvZEMgQl haWE4wSUZC byBZWEp0WV dObGRYIFJw WTJGc0lGTm wgY25acFky Vno0byBDWk lITnBaMjVw IFptbGpZVz UwSUggSnZi R1VnYVc0Zy BkR2hsSUhC b1lYIEp0WV dObGRYUnAg WTJGc0lHbH VaSCBWemRI SjVJR0Z1IF pDQnBkSE1n WTIgOXRiV2 wwYldWdSBk Q0IwYnlCcG JtIDV2ZG1G MGFXOXUgSU dGdVpDQnpk WCBOMFlXbH VZV0pwIGJH bDBlUzQ4WW 4gSSsKICAg ICAgICA8L3 NwYW4+CiAg ICAgICAgCi AgICAgICAg